We are live on ! Find out more
BSEM icon

BioStem Technologies

26 hedge funds and large institutions have $5.55M invested in BioStem Technologies in 2026 Q3 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

9.9% more ownership

Funds ownership: 0% → 9.9% (+9.9%)

Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BSEM Hedge Fund Activity: Q3 2026 in Review

26 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in BioStem Technologies (BSEM) for Q3 2026, worth a combined $5.55M.

Buyers outnumbered sellers: 26 funds opened new BSEM positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was PNC Financial Services Group, opening a new position worth an estimated $2.07M.

  • 26 institutional investors held BioStem Technologies (BSEM) as of Q3 2026, up from 0 in Q2 2026.
  • Funds reported $5.55M of BioStem Technologies stock for Q3 2026.
  • 26 funds opened new BioStem Technologies positions in Q3 2026 and 0 closed out, a net change of +26 holders.
  • The largest BioStem Technologies buyer in Q3 2026 was PNC Financial Services Group, an estimated $2.07M added.

Based on aggregated 13F filings for Q3 2026.